Tag Archives: clinical trials

Q&A with Kasha Witkos, SVP, Head of International Region, Alnylam Pharmaceuticals

Witkos discusses his accomplishments in his first year as SVP, Head of International Region, and his long-term goals to help maintain Alnylam’s leadership in RNAi. Alnylam (Cambridge, MA) is an RNAi therapy company whose ONPATTRO® (patisiran) became the world’s first approved RNAi therapeutic treatment in 2018. Since then, the company’s …

Read More »

FDA approves more drugs that haven’t been shown to work

Melody Petersen | Los Angeles Times Los Angeles – Federal regulators are increasingly approving drugs before studies have shown they work, leaving patients at risk of taking prescriptions that might harm but not help them. Last year, 14 new drugs received so-called expedited approval, in which they did not undergo …

Read More »

Big pharma tried to thwart Africa’s bid to manufacture Covid-19 vaccines locally

By PAULINE KAIRU BioNTech tried to thwart plans mooted by the World Health Organization for Africa to manufacture Covid-19 vaccines, according to an investigation by medical journal BMJ. Pointing to the kENUP Foundation, a consultancy firm hired by BioNTech, the BMJ said in its study published on February 9 that …

Read More »

Tackling the recruitment crisis in clinical trials

Why are so many clinical trials missing their recruitment deadlines, and what can be done to overcome this problem? Using clinical trials to validate new treatments is one of the most essential, yet expensive, processes in the global healthcare industry. These trials are not only expensive to conduct, but also …

Read More »

Ivermectin shows ‘antiviral effect’ against COVID, Japanese company says

The test tube with the Corona virus name label is seen in this illustration taken January 29, 2020. REUTERS/Dado Ruvic Join now for FREE unlimited access to Reuters.com Register TOKYO, Jan 31 (Reuters) – Japanese trading and pharmaceutical company Kowa Co Ltd (7807.T) said on Monday that the antiparasitic drug …

Read More »

What competition? Vertex touts Trikafta’s competitive edge after strong 2021

Vertex ended 2021 strong, crushing analysts’ sales expectations for the full year. CEO Reshma Kewalramani, MD says the company’s well-established position in the cystic fibrosis space, where Vertex expects to maintain its lead for years to come, is worth it. Vertex captured $7.57 billion in product revenue for 2021, reporting …

Read More »

Video games that diagnose, monitor and treat depression developed by scientists | Scientific and technical news

Scientists have developed video games using AI technology to diagnose, monitor and treat depression. The platform, called Thymia, aims to make depression and other mental health issues as measurable as physical ailments. Dr Emilia Molimpakis, CEO and co-founder of Thymia, told Sky News: “At the moment the existing system is …

Read More »

Psychobiotics Get Real: A Case Study

Are you in a rainy mood even when the sun is shining? You may be depressed. If so, you have plenty of company. The World Health Organization states that depression is the number one cause of disability worldwide. This is despite all the antidepressants, old and new, available in psychiatry. …

Read More »

Novartis CEO: We are moving towards filing Covid drugs with molecular partners with the FDA

Below is the unofficial transcript of an exclusive CNBC interview with Novartis (NYSE:NVS) CEO Dr. Vas Narasimhan on CNBC’s “Squawk on the Street” (MF 9AM – 11AM ET) today. , Wednesday 12 Januaryand. Here is a link to the video on CNBC.com: The six longest positions in this Odey fund …

Read More »

Central government panel recommends EUA for Covovax, Corbevax, Molnupiravir: reports

A central government panel from the Central Medicines Authority has recommended granting emergency use authorization (EUA) for the Serum Institute of India’s Covovax COVID-19 vaccine and the E Corbevax biologic vaccine, reported the PTI news agency. The Central Drugs Standard Control Organization (CDSCO) COVID-19 Subject Matter Expert Committee (SEC) also …

Read More »

How Seeing God May Be the Secret to Most Advanced Mental Health Treatments

[ad_1] Beautiful sunset over the island of Menorca, Spain with the sun’s rays breaking through the clouds and falling towards the sea getty During Seth Wilson’s last ketamine treatment, he intended to see his late mother. Wilson, a 41-year-old sommelier who owns a wine store in Chicago, has suffered from …

Read More »

Luye Pharma Reports First Results from Phase II Clinical Trial of New Ansofaxin Hydrochloride Extended-Release Antidepressant Tablets

[ad_1] CHONGQING, China, 23 December 2021 / PRNewswire / – Luye Pharma Group today released encouraging first results from a Phase II clinical trial of its new antidepressant, Ansofaxine Hydrochloride Extended-Release Tablets (LY03005), at 19e Chinese Medical Association National Psychiatry Conference. In general, LY03005 demonstrated overall antidepressant efficacy as well …

Read More »

EU regulators say no to Aduhelm, but Biogen pushes back

Dive brief: The regulator recommending the approval of new drugs in Europe does not believe Biogen’s Aduhelm should be allowed into the market, a position that could further jeopardize once high sales expectations for the new treatment for the disease. ‘Alzheimer’s. In delivering its negative opinion, the European Medicines Agency …

Read More »

Vincerx Pharma Announces Administration of First Patient in Phase 1 Ascending Dose Study of VIP152 for Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia or Richter Syndrome

[ad_1] PALO ALTO, Calif., December 17, 2021 (GLOBE NEWSWIRE) – Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to meet the unmet medical needs of cancer patients through paradigm shift therapies, announced today that the first patient received a dose in the Company’s Phase 1 dose escalation study of …

Read More »

Opportunities remain for effective and long-term treatments for bipolar depression

[ad_1] Bipolar disorder is a mental disorder characterized by periods of mania and depression. The current bipolar disorder treatment landscape includes a large number of established products that can effectively manage acute manic symptoms and reduce the frequency of relapses. The most consistently unmet clinical need highlighted by Key Opinion …

Read More »

CBT: stop your negative self-talk and reframe your thoughts with this therapy

[ad_1] It is the basis of cognitive behavioral therapy, which burst onto the psychological scene in the 1960s and has garnered accolades ever since. It may not be for everyone. Therapists typically assign “homework” which requires active participation on the part of the client and does not address underlying issues …

Read More »

ITC Launches Clinical Trials of Nasal Spray to Prevent Covid-19 Infection

The diversified conglomerate ITC is developing a nasal spray for the prevention of Covid-19 for which it has initiated clinical trials. An ITC spokesperson confirmed the development but said: “We are unable to share further details at this time as clinical trials are ongoing.” However, sources indicated that the product …

Read More »

Quris to launch AI-based clinical trial for fragile X syndrome in 2022

A candidate therapy for fragile X syndrome – developed using Quris’ bio-artificial intelligence clinical prediction platform – will enter clinical trials in 2022, the company said. Quris uses the power of artificial intelligence (AI) combined with a “patient-on-a-chip” platform to predict the safety and potential efficacy of drug candidates before …

Read More »

Vivalink remote patient monitoring provides superior data

Consumer health monitoring apps and devices have become popular tools to help individuals monitor and track their personal information. However, they are not the most viable data collection option for medical research. Pharmaceutical and clinical researchers looking for alternative ways to obtain data during the COVID-19 pandemic saw wearable devices, …

Read More »

Encouraging clinical trials in Wilson’s disease

[ad_1] Los Angeles, United States, October 26, 2021 (GLOBE NEWSWIRE) – Encouraging Wilson Disease Clinical Trials Strengthen Pipeline With Multiple Drugs In Pipeline, Says DelveInsight Several new therapies are under development for the treatment of Wilson’s disease. Among them, ALXN1840 and UX701 are at their most advanced stage (Phase III). …

Read More »

Experts examine advances in the use of photobiomodulation therapy to treat various brain disorders

[ad_1] Photobiomodulation (PBM) offers exciting opportunities to improve the lives of patients with a wide range of brain disorders. In this special collection of articles in the Alzheimer’s Disease Journal Experts are reviewing progress in using PBM therapy to treat dementia, Alzheimer’s disease, Parkinson’s disease and other disorders and suggest …

Read More »

Finding a way to treat ADHD in teens by stimulating their brains

[ad_1] The Boston Globe’s Ocean State Innovators Weekly presents a question-and-answer session with Rhode Island innovators who are launching new businesses and nonprofits, conducting groundbreaking research and reshaping the state’s economy. Send tips and suggestions to reporter Alexa Gagosz at [email protected] Researchers at Bradley Hospital are recruiting adolescents who have …

Read More »

More than 20 drugs in the pipeline to fight Covid

Merck’s Molnupiravir, Zydus Antibody Cocktail and Glenmark Nasal Spray are among more than 20 new drugs at different stages of drug trials or approvals in India to treat Covid-19. While the market for these drugs is not huge at the moment due to a drop in Covid-19 cases and extended …

Read More »

The Merck Covid-19 pill “remarkably effective”

Pharmaceutical giant Merck announced on Friday that it had produced its first effective anti-Covid-19 pill. Credit: Pixabay / Wiki / CC0 German pharmaceutical company Merck announced on Friday that trials indicate it has produced the first effective antiviral pill to fight Covid-19. Its drug, called molnupiravir, will be submitted to …

Read More »

Ovarian Cancer Pipeline Advanced Report: Current Therapies,

[ad_1] Los Angeles, United States, September 20, 2021 (GLOBE NEWSWIRE) – Ovarian Cancer Pipeline Advanced Report: Current Therapies, Emerging Drugs, and Treatment Prospects | SearchInsight There are approximately 50+ key companies developing therapies for advanced ovarian cancer. The drug candidates from ImmunoGen and OncoQuest Inc. are at the most advanced …

Read More »

Ocuphire Pharma present at two conferences in August

[ad_1] Canaccord Genuity 41st Annual Growth Conference to be held virtually August 10-12, 2021 HC Wainwright Virtual Conference on Ophthalmology August 17, 2021 FARMINGTON HILLS, Mich., Aug. 06, 2021 (GLOBE NEWSWIRE) – Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on the development and commercialization of therapies …

Read More »

Parkinson’s disease in the United States: market forecast to 2030 – ResearchAndMarkets.com

[ad_1] DUBLIN – (COMMERCIAL THREAD)–The “Parkinson’s disease – US market overview, epidemiology and forecast to 2030” report was added to ResearchAndMarkets.com offer. The Parkinson’s disease market size in the United States was valued at $ 1,390.1 million in 2020, according to the report. This market report offers an in-depth understanding …

Read More »

Active Pharmaceutical Ingredients Market Report

Visiongain has published a new report on Active Pharmaceutical Ingredients Market Report to 2031: API forecast (Branded / Innovative and Generic), by type of synthesis (Synthetic and Biotech), by application (diabetes, oncology, cardiovascular, central nervous system, analgesics and others) PLUS COVID-19 recovery scenarios. Impact of COVID-19 on the market for …

Read More »

USFDA grants Aduhelm approval as the first and only Alzheimer’s disease drug in nearly two decades, Health News, ET HealthWorld

[ad_1] CAMBRIDGE, Massachusetts and TOKYO, June 07, 2021 – Biogen and Eisai, Co., Ltd. announced today that the US FDA has granted fast track approval for Aduhelm â„¢ (aducanumab-avwa) as the first and only treatment for Alzheimer’s disease to treat a disease-defining pathology by reducing beta-amyloid plaques in the brain. …

Read More »

Tenax Therapeutics to join the Russell Microcap® Index

[ad_1] MORRISVILLE, NC – (COMMERCIAL THREAD) – Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that treat cardiovascular and pulmonary disease with high unmet medical need, is expected to join the Russell Microcap® Index at the conclusion of the Russell 2021 Indexes’ …

Read More »

Sources, Health News, ET HealthWorld

[ad_1] New Delhi: The only Indian company Zydus Cadila that claims to have developed a neutralizing monoclonal antibody (mAbs) cocktail for the treatment of Covid-19 has been authorized to conduct clinical trials by the Subject Expert Committee (SEC) of Central Drugs Standard Control Organization (CDSCO), sources say. “The SEC gives …

Read More »

Producing vaccines is not like making 2 minute noodles

[ad_1] Producing vaccines is not like making 2 minute noodles Sanjeev NayyarOn April 27, the Supreme Court asked the central government to explain the rationaleand basis for differential pricing of COVID-19 vaccines. He also asked the Center tohow he was going to respond to the sudden surge in demand for …

Read More »

5 ways the pharmaceutical industry is changing

[ad_1] Traditionally, the pharmaceutical industry has been slow to adopt new technologies and new ideas. There are several factors behind this: cumbersome regulations, intellectual property issues, complexity of manufacturing, high profit margins, and general risk aversion across the industry. A single decision to adopt a new technology or leadership paradigm …

Read More »

NRx Pharmaceuticals, Inc. begins trading on Nasdaq as NRXP, following merger between NeuroRx, Inc. and Big Rock Partners Acquisition Corp (Nasdaq: BRPA)

[ad_1] NRx Pharmaceuticals, Inc. Begins Trading on Nasdaq as NRXP Tweet this As a Nasdaq-listed company, NRx will deploy public capital to further develop two investigational drugs: ZYESAMI â„¢, (Aviptadil Acetate), the first investigational drug named by the FDA as Fast Track, to be studied in patients. critically ill with …

Read More »

the future of pharmaceutical services

[ad_1] Phase 1, phase 2 and phase 3 – the three key stages in a drug’s journey to market – and each stage is marked by its own complex processes, strict regulations and logistical challenges, hence the need to issue a license an average of ten years to new products. …

Read More »